PERSISTENT CARCINOMA INSITU OF THE TESTIS AFTER CHEMOTHERAPY FOR ADVANCED TESTICULAR GERM-CELL TUMORS

被引：34

作者：

BOTTOMLEY, D

FISHER, C

HENDRY, WF

HORWICH, A

机构：

[1] ROYAL MARSDEN HOSP,TESTICULAR TUMOUR UNIT,DOWNS RD,SUTTON SM2 5PT,SURREY,ENGLAND

[2] ROYAL MARSDEN HOSP,DEPT HISTOPATHOL,SUTTON SM2 5PT,SURREY,ENGLAND

来源：

BRITISH JOURNAL OF UROLOGY | 1990年 / 66卷 / 04期

关键词：

D O I：

10.1111/j.1464-410X.1990.tb14966.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Summary— The chemosensitivity of testicular carcinoma in situ (CIS) was analysed in 25 testes excised 10 weeks to 4.5 years following platinum‐based chemotherapy. CIS was present in 8 of the 23 evaluable cases (35%), in 5 of which the lesion coexisted with invasive germ cell tumour. It is concluded that CIS may persist or recur after chemotherapy. This has implications for occult presentation of metastatic germ cell tumours and also for the management of the contralateral testis in patients with testicular germ cell tumours. © 1990 British Journal of Urology

引用

页码：420 / 424

页数：5

共 30 条

[1] SCREENING FOR CARCINOMA INSITU OF THE CONTRALATERAL TESTIS IN PATIENTS WITH GERMINAL TESTICULAR CANCER [J].